Fig 2.TIF (531.51 kB)
Titres of anti-CD300e antibody in sera, as determined by ELISA.
figure
posted on 2016-08-11, 17:46 authored by Fumitaka Haseda, Akihisa Imagawa, Hiroyoshi Nishikawa, Shinobu Mitsui, Chiharu Tsutsumi, Reiko Fujisawa, Hiroyuki Sano, Yuko Murase-Mishiba, Jungo Terasaki, Shimon Sakaguchi, Toshiaki HanafusaA: Graph shows the titres of anti-CD300e antibody in sera from patients with fulminant type 1 diabetes in the acute phase (FT1D, A: n = 26), FT1D in the sub-acute phase (FT1D, SA: n = 26), FT1D in chronic phase (FT1D, C: n = 13), type 1A diabetes (T1AD: n = 32), type 2 diabetes (T2D: n = 30), autoimmune thyroid disease (AITD: n = 22) and healthy control subjects (HC: n = 31). The bars indicate the median. B: Graph shows comparison of the anti-CD300e antibody titres between FT1D patients in the acute phase (A) and those in the sub-acute phase (SA). The units are all OD (arbitrary unit).
